Search Results - "Skotnicki, Jerauld"
-
1
Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate
Published in Proceedings of the National Academy of Sciences - PNAS (22-03-2011)“…The macrocyclic polyketides FK506, FK520, and rapamycin are potent immunosuppressants that prevent T-cell proliferation through initial binding to the…”
Get full text
Journal Article -
2
Synthesis of rapamycin glycoconjugates via a CuAAC-based approach
Published in Tetrahedron letters (01-12-2013)“…The conversion of the C40 secondary hydroxyl group of rapamycin into the azido group was followed by copper catalyzed cycloaddition of the resulting…”
Get full text
Journal Article -
3
Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway
Published in Cancer research (Chicago, Ill.) (01-08-2009)“…Uterine leiomyomata, or fibroids, are benign tumors of the uterine myometrium that significantly affect up to 30% of reproductive-age women. Despite being the…”
Get full text
Journal Article -
4
Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities
Published in Proceedings of the National Academy of Sciences - PNAS (08-01-2008)“…Rapamycin is an immunosuppressive immunophilin ligand reported as having neurotrophic activity. We show that modification of rapamycin at the mammalian target…”
Get full text
Journal Article -
5
Recombinant strains for the enhanced production of bioengineered rapalogs
Published in Metabolic engineering (01-01-2013)“…The rapK gene required for biosynthesis of the DHCHC starter acid that initiates rapamycin biosynthesis was deleted from strain BIOT-3410, a derivative of…”
Get full text
Journal Article -
6
Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
Published in Bioorganic & medicinal chemistry (15-12-2005)“…Modification of α-biphenylsulfonamidocarboxylic acids led to potent and selective MMP-13 inhibitors. Compound 16 showed 100% oral bioavailability in rats and…”
Get full text
Journal Article -
7
Synthesis and SAR of highly selective MMP-13 inhibitors
Published in Bioorganic & medicinal chemistry letters (15-11-2005)“…The structure-based design and synthesis of a series of novel biphenyl sulfonamide carboxylic acids as potent MMP-13 inhibitors with selectivity over MMP-1,…”
Get full text
Journal Article -
8
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors
Published in Cancer biology & therapy (01-05-2005)“…Deregulated phosphatidylinositol 3-kinase (PI3K) signaling pathway is widely implicated in tumor growth and resistance to chemotherapy. While a strong…”
Get full text
Journal Article -
9
3,4-Disubstituted benzofuran P1′ MMP-13 inhibitors: Optimization of selectivity and reduction of protein binding
Published in Bioorganic & medicinal chemistry letters (15-08-2009)“…Potent and selective 3,4-disubstituted benzofuran P1′ MMP-13 inhibitors have been prepared with a substituent at the C4 position of the benzofuran P1′ moiety…”
Get full text
Journal Article -
10
Synthesis and Structure−Activity Relationship of N-Substituted 4-Arylsulfonylpiperidine-4-hydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis
Published in Journal of medicinal chemistry (05-06-2003)“…The matrix metalloproteinases (MMPs) are a family of zinc-containing endopeptidases that play a key role in both physiological and pathological tissue…”
Get full text
Journal Article -
11
Synthesis and Structure−Activity Relationship of α-Sulfonylhydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis
Published in Journal of medicinal chemistry (05-06-2003)“…The matrix metalloproteinases (MMPs) are a family of zinc-containing endopeptidases that play a key role in both physiological and pathological tissue…”
Get full text
Journal Article -
12
Synthesis and Structure−Activity Relationships of 4-alkynyloxy Phenyl Sulfanyl, Sulfinyl, and Sulfonyl Alkyl Hydroxamates as Tumor Necrosis Factor-α Converting Enzyme and Matrix Metalloproteinase Inhibitors
Published in Journal of medicinal chemistry (02-12-2004)“…A series of 4-alkynyloxy phenyl sulfanyl, sulfinyl and sulfony alkyl and piperidine-4-carboxylic acid hydroxamides were synthesized. Their structure−activity…”
Get full text
Journal Article -
13
2-phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis
Published in Bioorganic & medicinal chemistry letters (04-08-2003)“…Twenty-five 2-phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives were synthesized for evaluation as new inhibitors of bacterial cell wall…”
Get full text
Journal Article -
14
NMR Solution Structure of the Catalytic Fragment of Human Fibroblast Collagenase Complexed with a Sulfonamide Derivative of a Hydroxamic Acid Compound
Published in Biochemistry (Easton) (01-06-1999)“…The solution structure of the catalytic fragment of human fibroblast collagenase (MMP-1) complexed with a sulfonamide derivative of a hydroxamic acid compound…”
Get full text
Journal Article -
15
Benzodiazepine inhibitors of the MMPs and TACE
Published in Bioorganic & medicinal chemistry letters (21-10-2002)“…A series of benzodiazepine inhibitors of the MMPs and TACE has been developed. These compounds display an interesting selectivity profile and should be useful…”
Get full text
Journal Article -
16
Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases
Published in Bioorganic & medicinal chemistry letters (22-01-2001)“…Heteroaryl and cycloalkyl sulfonamide-hydroxamic acid MMP inhibitors were investigated. Of these, the pyridyl analogue 2 is the most potent and selective…”
Get full text
Journal Article -
17
The synthesis and biological activity of a novel series of diazepine MMP inhibitors
Published in Bioorganic & medicinal chemistry letters (06-10-1998)“…A novel series of diazepine-based hydroxamic acid inhibitors of MMP-1, MMP-9, and MMP-13 were prepared and evaluated both in vitro and in vivo. A novel series…”
Get full text
Journal Article -
18
Design strategies for the identification of MMP-13 and Tace inhibitors
Published in Current opinion in drug discovery & development (01-09-2003)“…Inhibitors of matrix metalloprotease (MMP)-13 and tumor necrosis factor-alpha converting enzyme (TACE) have been highly sought as potential therapeutic agents…”
Get more information
Journal Article -
19
Synthesis and biological evaluation of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides: A class of potent aggrecanase-1 inhibitors
Published in Bioorganic & medicinal chemistry letters (01-05-2009)“…A subset of ((4-keto)-phenoxy)methyl biphenyl-4-sulfonamides were identified as potent Agg-1, MMP-2 and MMP-13 inhibitors through the synthesis of a series of…”
Get full text
Journal Article -
20
Pegylated Wortmannin and 17-Hydroxywortmannin Conjugates as Phosphoinositide 3-Kinase Inhibitors Active in Human Tumor Xenograft Models
Published in Journal of medicinal chemistry (23-02-2006)“…Phosphoinositide 3-kinase (PI3K) is an important target for cancer chemotherapy due to the deregulation of its signaling pathway in a wide spectrum of human…”
Get full text
Journal Article